Form 4: Rigel Pharmaceuticals EVP Raymond Furey Reports Stock Sales to Cover Tax Withholding

Raymond Furey, EVP, GC, CCO & Corp Sec of Rigel Pharmaceuticals, sold shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• Raymond J. Furey, an executive at Rigel Pharmaceuticals, reported the sale of company stock.
• The transactions occurred on February 4th and 5th, 2025.
• A total of 1,448 shares were sold on February 4th at a price of $20.921 per share.
• On February 5th, 1,339 shares were sold at $21.926 per share.
• These sales were to cover tax withholding obligations due upon the vesting of Restricted Stock Units.
• Following these transactions, Furey directly owns 38,830 shares of Rigel Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports stock sales to cover tax obligations, which is a routine event. There is no indication of positive or negative sentiment towards the company's prospects.

Management Comments

• The sales to cover were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions by key personnel.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

Keywords

Form 4, Rigel Pharmaceuticals, RIGL, Raymond Furey, Stock Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership, Executive Compensation